Atlas Trials

Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

Clinical trial NCT03325595 · COMPLETED

Trial details

NCT number
NCT03325595
Sponsor
Aelis Farma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2017-04-06
Primary completion
2018-02-26
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.